Jenburkt Pharmaceuticals Share Price

BSE
1309.75
+15.90 (1.23%)
JENBURPH • 20 Jun, 2025 | 03:30 PM
BUY

1Y Annualised Return

47.27%

3Y Annualised Return

38.97%

5Y Annualised Return

27.07%

The current prices are delayed, login or Open Demat Account for live prices.

Jenburkt Pharmaceuticals SIP Return Calculator

Over the past

1 year
3 years
5 years

Total Investment of ₹65,00,000

Would have become ₹83,15,504 (+27.93%)

Daily SIP of 25,000 would have become 83,15,504 in 1 year with a gain of 18,15,504 (+27.93%)

Jenburkt Pharmaceuticals Stock Performance
Today’s Low - High
1,263.00
1,310.00
1,263.00
1,310.00
52 Week Low - High
815.80
1,375.00
815.80
1,375.00

Open

1,286.00

Prev. Close

1,293.85

Volume

694.00

Total Traded Value

9.02 L

View details of Market Depth
Jenburkt Pharmaceuticals Fundamental

Market Cap (in crs)

573.62

Face Value

10

Turnover (in lacs)

9.02

Key Metrics
Qtr Change %
New 52W High in past week
30.6
Dividend yield 1yr %
High in industry
1.2

Jenburkt Pharmaceuticals shareholding Pattern

Promoter
46.7%
Domestic Institutions
0.1%
Public
53.2%
Promoter
46.7%
Domestic Institutions
0.1%
Public
53.2%
Promoter
46.7%
Public
53.3%
Promoter
46.7%
Public
53.3%
Promoter
47.2%
Public
52.8%
Promoter
47.4%
Public
52.6%

Jenburkt Pharmaceuticals Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
1309.75
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
2
5Day EMA
1,307.60
10Day EMA
1,294.60
12Day EMA
1,286.60
20Day EMA
1,253.10
26Day EMA
1,230.70
50Day EMA
1,172.80
100Day EMA
1,130.90
200Day EMA
1,083.60
5Day SMA
1,319.40
10Day SMA
1,299.30
20Day SMA
1,249.80
30Day SMA
1,197.70
50Day SMA
1,138.30
100Day SMA
1,087.80
150Day SMA
1,135.80
200Day SMA
1,121.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
453 Rs
694 Rs
Week Rs
1095 Rs
1523 Rs
Month Rs
1988 Rs
2543 Rs
Resistance & Support
1,290.92
Pivot
Resistance
First Resistance
1,318.83
Second Resistance
1,337.92
Third Resistance
1,365.83
Support
First Support
1,271.83
Second support
1,243.92
Third Support
1,224.83
Relative Strength Index
63.39
Money Flow Index
66.65
MACD
55.90
MACD Signal
56.78
Average True Range
55.98
Average Directional Index
35.19
Rate of Change (21)
12.64
Rate of Change (125)
-1.14

Jenburkt Pharmaceuticals Latest News

20 JUN 2025 | Friday

Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date

20 JUN 2025 | Friday

Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 40Th Annual General Meeting Of The Company Schedule To Be Held On Friday, 18Th July, 2025 Through VC/OAVM.

20 JUN 2025 | Friday

Jenburkt Pharmaceuticals Ltd - 524731 - Reg. 34 (1) Annual Report.

View More

Jenburkt Pharmaceuticals Company background

Founded in: 1985
Managing director: Ashish U Bhuta
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.

As of 20 Jun, 2025, Jenburkt Pharmaceuticals share price is ₹1299.8. The stock opened at ₹1286 and had closed at ₹1293.8 the previous day. During today’s trading session, Jenburkt Pharmaceuticals share price moved between ₹1,263.00 and ₹1,310.00, with an average price for the day of ₹1286.50. Over the last 52 weeks, the stock has recorded a low of ₹815.80 and a high of ₹1,375.00. In terms of performance, Jenburkt Pharmaceuticals share price has increased by 4.6% over the past six months and has increased by 47.27% over the last year.

Read More

Jenburkt Pharmaceuticals FAQs

You can easily buy Jenburkt Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Jenburkt Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -